ANG Lifesciences India Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from ANG Lifesciences India Ltd. on BSE

Search Inside the pdf :

ANG Lifesciences India Ltd.

01 Apr 2025

27.60

4.98%

SAST

ANG Lifesciences India Ltd - 540694 - Closure of Trading Window

BSE India

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time read with Company''s Code of Conduct to regulate, monitor and report the trading of equity shares. The trading window for dealing in the securities of company shall remain closed from 1st April, 2025 for the insider, designated persons and their immediate relatives till the end of 48 hours after declaration of Results for the quarter ending 31st, March 2025.

pdf

ANG Lifesciences India Ltd.

20 Mar 2025

27.60

4.98%

Company Update

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Karun Singh, Group Opertaions Head of the Company had a Zoom meet with Mr. Milin Ramani on 20-MArch-2025.

pdf

ANG Lifesciences India Ltd.

12 Mar 2025

27.60

4.98%

Company Update

ANG Lifesciences India Ltd - 540694 - Appointment of Company Secretary and Compliance Officer

BSE India

Pursuant to Regulation 30 of SEBI (LODR), Regulations 2015, the Board of Directors at the meeting held on today March 12, 2025 have considered and appointed Ms. Harshita Aggarwal as the Company Secretary and Compliance Officer of the company w.e.f March 12, 2025.

pdf

ANG Lifesciences India Ltd.

15 Feb 2025

27.60

4.98%

Company Update

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Enclosed are the newspaper publication of Unaudited Financial Results 31.12.2024.

pdf

ANG Lifesciences India Ltd.

14 Feb 2025

27.60

4.98%

Corp. Note

ANG Lifesciences India Ltd - 540694 - Integrated Filing (Financial)

BSE India

Integrated Filling (Financials)

pdf

ANG Lifesciences India Ltd.

14 Feb 2025

27.60

4.98%

Result

ANG Lifesciences India Ltd - 540694 - UNAUDITED FINANCIAL RESULTS FOR Q.E. 31-12-2024

BSE India

Unaudited Financial Results for Quarter and nine months ended 31.12.2024.

pdf

ANG Lifesciences India Ltd.

14 Feb 2025

27.60

4.98%

Board Meeting

ANG Lifesciences India Ltd - 540694 - Board Meeting Outcome for Board Meeting Outcome For SUBMISSION …

BSE India

Pursuant to Regulation 30 & 33 read with clause 4 (h) of Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulation, 2015 (''Listing Regulations''), this is to inform your that Board of Directors in its meeting held today i.e., February 14, 2025, have inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024, along with Limited Review Report issued by Statutory Auditors of the Company. A copy of the same is enclosed herewith.

pdf

ANG Lifesciences India Ltd.

06 Feb 2025

27.60

4.98%

Board Meeting

ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Board Meeting Intimation For Board …

BSE India

ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve the Unaudited Standalone & Consolidated Financial Results for the Quarter and Nine months ended December 31, 2024 along with Limited Review Report.

pdf